SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of May 2022
Commission File Number: 001-40952
Babylon Holdings Limited
1 Knightsbridge Green
London, SW1X 7QA
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
Beginning on May 3, 2022, Babylon Holdings Limited (the “Company”) will make available presentation slides, dated May 2022, for use during investor meetings (the “Investor Presentation”). The Investor Presentation is posted on the Investor Relations page of the Company’s website at https://ir.babylonhealth.com. A copy of the Investor Presentation is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
|99.1||Investor Presentation, May 2022|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|Babylon Holdings Limited|
|Date: May 3, 2022||/s/ Charlie Steel|
|Chief Financial Officer|